AlloVir Inc. (ALVR) Social Stream



AlloVir Inc. (ALVR): $4.44

0.31 (+7.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALVR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Allovir Inc (ALVR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ALVR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 4 $55 $37 $45 $7.06 537.39%
2021-12-13 4 $55 $36 $44 $7.06 523.23%
2021-12-19 4 $55 $32 $42.75 $7.06 505.52%
2022-01-18 4 $55 $32 $42 $7.06 494.9%
2022-01-31 4 $55 $32 $38.75 $7.06 448.87%
2022-02-11 4 $55 $30 $37.5 $7.06 431.16%

The Trend in the Analyst Price Target


Over the past 28 weeks, ALVR's average price target has gone down $11.5.

ALVR reports an average of 171.99% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-14 1 55 41 48.00 23.56 103.74%
2021-05-15 3 55 42 49.00 24.00 104.17%
2021-05-21 3 55 42 49.00 21.57 127.17%
2021-08-04 3 55 42 49.00 19.67 149.11%
2021-09-04 3 55 40 45.75 20.21 126.37%

ALVR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.13 3 1 0 0 0 4

The Trend in the Broker Recommendations


Over the past 18 months, ALVR's average broker recommendation rating worsened by 0.25.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALVR as an investment opportunity.

  • Allovir Inc's upside potential (average analyst target price relative to current price) is greater than 578.33% of all US stocks.
  • ALVR has a higher number of analysts covering the stock than 114.48% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Allovir Inc's variance in analysts' estimates is lower than -305.89% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Allovir Inc's average analyst price target is greater than 376.76% of them.

In the Pharmaceutical Products industry, ALLO, AERI, and ADGI are the three stocks most similar to Allovir Inc regarding the price target and analyst recommendation information presented here.

Is ALVR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6371 seconds.